These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8973755)

  • 41. Interactions between angiotensin II and norepinephrine on renin release by juxtaglomerular cells.
    Ichihara A; Suzuki H; Murakami M; Naitoh M; Matsumoto A; Saruta T
    Eur J Endocrinol; 1995 Nov; 133(5):569-77. PubMed ID: 7581987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels.
    Diep QN; Li JS; Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 1):617-24. PubMed ID: 10523336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S
    Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pouch tissue and angiotensin peptide generation.
    Katwa LC; Sun Y; Campbell SE; Tyagi SC; Dhalla AK; Kandala JC; Weber KT
    J Mol Cell Cardiol; 1998 Jul; 30(7):1401-13. PubMed ID: 9710808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Losartan inhibition of angiotensin-related drinking and Fos immunoreactivity in hypertensive and hypotensive contexts.
    Rowland NE; Morien A; Fregly MJ
    Brain Res; 1996 Dec; 742(1-2):253-9. PubMed ID: 9117402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.
    Goldberg MR; Tanaka W; Barchowsky A; Bradstreet TE; McCrea J; Lo MW; McWilliams EJ; Bjornsson TD
    Hypertension; 1993 May; 21(5):704-13. PubMed ID: 8491505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
    Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats.
    Li JS; Touyz RM; Schiffrin EL
    Hypertension; 1998 Jan; 31(1 Pt 2):487-92. PubMed ID: 9453350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between the renin-angiotensin system (RAS) and the sympathetic system.
    Dendorfer A; Raasch W; Tempel K; Dominiak P
    Basic Res Cardiol; 1998; 93 Suppl 2():24-9. PubMed ID: 9833158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction.
    Pimentel JL; Wang S; Martinez-Maldonado M
    Kidney Int; 1994 Jun; 45(6):1614-21. PubMed ID: 7933808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of chronic treatment with losartan potassium (DuP 753) on the elevation of blood pressure during chronic exposure of rats to cold.
    Fregly MJ; Rossi F; Van Bergen P; Brummermann M; Cade JR
    Pharmacology; 1993 Apr; 46(4):198-205. PubMed ID: 8483966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of losartan on potassium-stimulated aldosterone secretion in vitro.
    Chiou CY; Kifor I; Moore TJ; Williams GH
    Endocrinology; 1994 Jun; 134(6):2371-5. PubMed ID: 8194463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB; Smith RD
    Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.